UBS Group’s iHuman IH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $181 | Buy |
129
+30
| +30% | +$48 | ﹤0.01% | 10022 |
|
|
2026
Q1 | $169 | Sell |
99
-90
| -48% | -$167 | ﹤0.01% | 10057 |
|
|
2025
Q4 | $397 | Buy |
189
+187
| +9,350% | +$495 | ﹤0.01% | 9986 |
|
|
2025
Q3 | $6 | Sell |
2
-4,868
| -100% | -$13.5K | ﹤0.01% | 10222 |
|
|
2025
Q2 | $12.2K | Buy |
4,870
+3,766
| +341% | +$8.39K | ﹤0.01% | 8748 |
|
|
2025
Q1 | $2.34K | Sell |
1,104
-2,210
| -67% | -$4.41K | ﹤0.01% | 9357 |
|
|
2024
Q4 | $5.6K | Sell |
3,314
-1,212
| -27% | -$2.17K | ﹤0.01% | 8631 |
|
|
2024
Q3 | $10.4K | Buy |
+4,526
| New | +$7.41K | ﹤0.01% | 7726 |
|
|
2023
Q4 | – | Sell |
-181
| Closed | -$547 | – | 9577 |
|
|
2023
Q3 | $547 | Buy |
+181
| New | +$560 | ﹤0.01% | 8413 |
|
|
2023
Q2 | – | Sell |
-53
| Closed | -$172 | – | 9226 |
|
|
2023
Q1 | $172 | Sell |
53
-1,912
| -97% | -$6.16K | ﹤0.01% | 9160 |
|
|
2022
Q4 | $5.11K | Sell |
1,965
-1,692
| -46% | -$3.44K | ﹤0.01% | 9221 |
|
|
2022
Q3 | $8K | Buy |
3,657
+710
| +24% | +$1.55K | ﹤0.01% | 8719 |
|
|
2022
Q2 | $7K | Buy |
+2,947
| New | +$7.76K | ﹤0.01% | 8493 |
|
|
2022
Q1 | – | Sell |
-3,990
| Closed | -$11K | – | 10534 |
|
|
2021
Q4 | $11K | Buy |
3,990
+3,169
| +386% | +$13.6K | ﹤0.01% | 8670 |
|
|
2021
Q3 | $4K | Buy |
+821
| New | +$6.11K | ﹤0.01% | 8645 |
|
|
2021
Q2 | – | Sell |
-549
| Closed | -$7K | – | 9568 |
|
|
2021
Q1 | $7K | Buy |
+549
| New | +$9.69K | ﹤0.01% | 8152 |
|
Other funds holding IH
UBS Group's IH Position: Q2 2026 in Review
UBS Group increased its iHuman (IH) stake by 30% in Q2 2026, buying an estimated $48 and bringing the position to 129 shares worth $181. The position accounts for ﹤0.01% of the portfolio, ranked #10022.
UBS Group first reported a position in IH in Q1 2021 and has held it in 16 quarters since. The position peaked at $12.2K in Q2 2025. 4 funds tracked by Wall St. Rank hold IH as of Q2 2026.
- UBS Group held 129 shares of iHuman worth $181 as of Q2 2026.
- UBS Group bought 30 iHuman shares in Q2 2026, an estimated $48.
- iHuman made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #10022 holding.
- UBS Group first reported a position in iHuman in Q1 2021 and has held it in 16 quarters since.
- UBS Group's iHuman position peaked at $12.2K in Q2 2025.
- 4 funds tracked by Wall St. Rank held iHuman as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.